Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chris Polman, MD
VU Medical Centre
Principal Investigator - Michael Panzara, MD, MPH
Biogen
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
53 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Algemeen Ziekenhuis St. Jan
Bruges, Belgium
- Luc- University Centre
Diepenbeek, Belgium
- National Ms Centrum
Melsbroek, Belgium
- Vancouver Hospital and Health Sciences Center Ubc Pavilion, Ms Clinical Research Group
Vancouver, British Columbia, Canada
- Health Services Centre
Winnipeg, Manitoba, Canada
- Kingston General Hospital, Neurology
Kingston, Ontario, Canada
- University Hospital
London, Ontario, Canada
- Sunnybrook and Women'S College and Health Science Centre
Toronto, Ontario, Canada
- University of Toronto, Ms Clinic, St. Michael'S Hospital
Toronto, Ontario, Canada
- Chvo Hull Hospital
Québec, Quebec, Canada
- Ms Research Unit, Center for Clinical Research
Halifax, Canada
- Family Medical Centre
Ottawa, Canada
- Faculty Hospital Brno Bohunice
Brno, Czechia
- Faculty Hospital St. Anne
Brno, Czechia
- Faculty Hospital of Hradec Kralove
Hradec Králové, Czechia
- Faculty Hospital Olomouc
Olomouc, Czechia
- Faculty Hospital of Ostrava Poruba
Ostrava, Czechia
- Hospital Pardubice - Department of Neurology
Pardubice, Czechia
- Faculty Hospital Plzen - Clinic of Neurology
Pilsen, Czechia
- Faculty Hospital Motol - Neurological Clinic
Prague, Czechia
- General Teaching Hospital - Neurological Department
Prague, Czechia
- Hopital de la Timone, Service de Neurologie
Marseille, France
- Chru - Hopital de Pontchaillou, Service de Neurologie
Rennes, France
- St. Josef-Hospital, Neurologische Klinik Der Ruhruniversitat Bochum
Bochurn, Germany
- Klinika Neurologii
Bydgoszcz, Germany
- Academisch Ziekenhuis Vu
Amsterdam, Netherlands
- Institute of Neurology
Queen Square, London, United Kingdom
- the Royal London Hospital
Whitechapel, London, United Kingdom
- Atkin'S Morely Hospital
Wimbledon, London, United Kingdom
- Oldchurch Hospital
Essex, United Kingdom
- Ipswich Hospital Nhs Trust - Department of Clinical Neurology
Ipswich, United Kingdom
- St. James University Hospital, Department of Neurology
Leeds, United Kingdom
- Guy'S Hospital
London, United Kingdom
- King'S College Hospital
London, United Kingdom
- Kings College Hospital, Kings Neuroscience Center
London, United Kingdom
- Royal Victoria Infirmary
Newcastle upon Tyne, United Kingdom
- the Radcliffe Infirmary, University Department of Clinical Neurology
Oxford, United Kingdom
- Royal Hallamshire Hospital
Sheffield, United Kingdom
- North Staffordshire Royal Infirmary - Neurology Department
Stoke-on-Trent, United Kingdom
- Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2001
- Primary completion
- 30 Nov 2004
- Completion
- 31 Jan 2005
- Last update posted
- 9 Jan 2017
- Registered enrollment
- 900
- Registry id
- NCT00027300
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.